Targeting the mevalonate pathway in multiple myeloma

被引：3
|
作者：
van der Spek, Ellen [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Hematol, NL-3584 CX Utrecht, Netherlands
来源：
LEUKEMIA RESEARCH | 2010年 / 34卷 / 03期
关键词：
Multiple myeloma; Mevalonate pathway; Plasma cell lines; FPP; GGPP; CELL-LINES; DRUG-RESISTANCE; PLASMA-CELLS; APOPTOSIS; SIMVASTATIN; INHIBITOR; SURVIVAL; PROTEIN; GERANYLGERANYLATION; FARNESYLATION;
D O I：
10.1016/j.leukres.2009.07.027
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [1] New treatment strategies for multiple myeloma by targeting BCL-2 and the mevalonate pathway
    van de Donk, NWCJ
    Bloem, AC
    van der Spek, E
    Lokhorst, HM
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 327 - 340
  • [2] Inhibitors of the mevalonate pathway as potential therapeutic agents in multiple myeloma
    Baulch-Brown, Cindy
    Molloy, Timothy J.
    Yeh, Sung Lin
    Ma, David
    Spencer, Andrew
    LEUKEMIA RESEARCH, 2007, 31 (03) : 341 - 352
  • [3] Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
    Clendening, James W.
    Pandyra, Aleksandra
    Li, Zhihua
    Boutros, Paul C.
    Martirosyan, Anna
    Lehner, Richard
    Jurisica, Igor
    Trudel, Suzanne
    Penn, Linda Z.
    BLOOD, 2010, 115 (23) : 4787 - 4797
  • [4] Targeting the Mevalonate Pathway in Cancer
    Juarez, Dennis
    Fruman, David A.
    TRENDS IN CANCER, 2021, 7 (06): : 525 - 540
  • [5] Selinexor: Targeting a novel pathway in multiple myeloma
    Mo, Clifton C.
    Yee, Andrew J.
    Midha, Shonali
    Hartley-Brown, Monique A.
    Nadeem, Omar
    O'Donnell, Elizabeth K.
    Bianchi, Giada
    Sperling, Adam S.
    Laubach, Jacob P.
    Richardson, Paul G.
    EJHAEM, 2023, 4 (03): : 792 - 810
  • [6] Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma
    Haney, Staci L. L.
    Holstein, Sarah A. A.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)
  • [7] The mevalonate pathway is an actionable vulnerability oft(4;14)-positive multiple myeloma
    Longo, Joseph
    Smirnov, Petr
    Li, Zhihua
    Branchard, Emily
    van Leeuwen, Jenna E.
    Licht, Jonathan D.
    Haibe-Kains, Benjamin
    Andrews, David W.
    Keats, Jonathan J.
    Pugh, Trevor J.
    Trudel, Suzanne
    Penn, Linda Z.
    LEUKEMIA, 2021, 35 (03) : 796 - 808
  • [8] The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma
    Joseph Longo
    Petr Smirnov
    Zhihua Li
    Emily Branchard
    Jenna E. van Leeuwen
    Jonathan D. Licht
    Benjamin Haibe-Kains
    David W. Andrews
    Jonathan J. Keats
    Trevor J. Pugh
    Suzanne Trudel
    Linda Z. Penn
    Leukemia, 2021, 35 : 796 - 808
  • [9] Targeting prenylation inhibition through the mevalonate pathway
    Manaswiyoungkul, Pimyupa
    de Araujo, Elvin D.
    Gunning, Patrick T.
    RSC MEDICINAL CHEMISTRY, 2020, 11 (01): : 51 - 71
  • [10] Bactericidal potential of drugs targeting the mevalonate pathway
    Weber, L.
    Hagemann, A.
    Jebens, H.
    Besser, M.
    Schlobach, J.
    Rockenfeller, P.
    Ehrhardt, A.
    Stuermer, E.
    Bachmann, H. S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S25 - S25
12345